QuidelOrtho Corp (QDEL)
39.67
+0.59
(+1.51%)
USD |
NASDAQ |
Apr 23, 12:10
QuidelOrtho Cash from Investing (Quarterly): -55.10M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -55.10M |
| September 30, 2023 | -21.30M |
| June 30, 2023 | -42.30M |
| March 31, 2023 | -68.90M |
| December 31, 2022 | -59.30M |
| September 30, 2022 | -29.80M |
| June 30, 2022 | -1.530B |
| March 31, 2022 | -24.70M |
| December 31, 2021 | -96.00M |
| September 30, 2021 | -93.20M |
| June 30, 2021 | -65.73M |
| March 31, 2021 | -64.57M |
| December 31, 2020 | -27.21M |
| September 30, 2020 | -22.72M |
| June 30, 2020 | -7.504M |
| March 31, 2020 | -5.884M |
| December 31, 2019 | -8.513M |
| September 30, 2019 | -6.932M |
| June 30, 2019 | -6.791M |
| March 31, 2019 | -4.993M |
| December 31, 2018 | -8.814M |
| September 30, 2018 | -9.298M |
| June 30, 2018 | -8.628M |
| March 31, 2018 | 141.70M |
| December 31, 2017 | -404.60M |
| Date | Value |
|---|---|
| September 30, 2017 | -4.43M |
| June 30, 2017 | -19.01M |
| March 31, 2017 | -3.712M |
| December 31, 2016 | -4.049M |
| September 30, 2016 | -2.403M |
| June 30, 2016 | -3.423M |
| March 31, 2016 | -7.095M |
| December 31, 2015 | -5.029M |
| September 30, 2015 | -4.655M |
| June 30, 2015 | -4.481M |
| March 31, 2015 | -2.867M |
| December 31, 2014 | -2.657M |
| September 30, 2014 | -1.873M |
| June 30, 2014 | -2.652M |
| March 31, 2014 | -4.059M |
| December 31, 2013 | -4.175M |
| September 30, 2013 | -7.72M |
| June 30, 2013 | -18.30M |
| March 31, 2013 | -3.742M |
| December 31, 2012 | -5.453M |
| September 30, 2012 | -4.112M |
| June 30, 2012 | -3.164M |
| March 31, 2012 | -15.87M |
| December 31, 2011 | -3.617M |
| September 30, 2011 | -14.56M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-1.530B
Minimum
Jun 2022
-5.884M
Maximum
Mar 2020
-117.73M
Average
-29.80M
Median
Sep 2022
Cash from Investing (Quarterly) Benchmarks
| Abbott Laboratories | -824.00M |
| Becton Dickinson & Co | -233.00M |
| Boston Scientific Corp | -1.053B |
| Tenon Medical Inc | -0.092M |
| Perspective Therapeutics Inc | -0.089M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 80.40M |
| Cash from Financing (Quarterly) | -57.80M |
| Free Cash Flow | 70.90M |
| Free Cash Flow Per Share (Quarterly) | 0.476 |
| Free Cash Flow to Equity (Quarterly) | 84.80M |
| Free Cash Flow to Firm (Quarterly) | -2.896M |
| Free Cash Flow Yield | 2.67% |